Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer.

Cardin, D. B.,Goff, L.,Li, C. I.,Shyr, Y.,Winkler, C.,Devore, R.,Schlabach, L.,Holloway, M.,McClanahan, P.,Meyer, K.,Grigorieva, J.,Berlin, J.,Chan, E.; Cancer Med. 2014 Feb 28.

A phase II study of concurrent chemoradiotherapy with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and ca...

Hughes RS, Sandler AB, Jain AK, Dowlati A, Schwartzberg LS, Dobbs T, Schlabach L, Wu J, Muldowney NJ, Choy H; J. Clin. Oncol.. 2008-05-20.

57 citations Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer.

Heymach, J. V., Johnson, D. H., Khuri, F. R., Safran, H., Schlabach, L. L., Yunus, F., DeVore, R. F., De Porre, P. M., Richards, H. M., Jia, X., Zhang, S., Johnson, B. E.; Ann Oncol. 2004 Aug.